Fun A - Search Results

1

Mutation Q95K enhances N155H-mediated integrase inhibitor resistance and improves viral replication capacity.

Fun A, Van Baelen K, van Lelyveld SF, Schipper PJ, Stuyver LJ, Wensing AM, Nijhuis M. Fun A, et al. J Antimicrob Chemother. 2010 Nov;65(11):2300-4. doi: 10.1093/jac/dkq319. Epub 2010 Aug 24. J Antimicrob Chemother. 2010. PMID: 20736234

2

Failure of treatment with first-line lopinavir boosted with ritonavir can be explained by novel resistance pathways with protease mutation 76V.

Nijhuis M, Wensing AM, Bierman WF, de Jong D, Kagan R, Fun A, Jaspers CA, Schurink KA, van Agtmael MA, Boucher CA. Nijhuis M, et al. Among authors: fun a. J Infect Dis. 2009 Sep 1;200(5):698-709. doi: 10.1086/605329. J Infect Dis. 2009. PMID: 19627247

3

HIV-1 protease inhibitor mutations affect the development of HIV-1 resistance to the maturation inhibitor bevirimat.

Fun A, van Maarseveen NM, Pokorná J, Maas RE, Schipper PJ, Konvalinka J, Nijhuis M. Fun A, et al. Retrovirology. 2011 Aug 24;8:70. doi: 10.1186/1742-4690-8-70. Retrovirology. 2011. PMID: 21864346 Free PMC article.

4

Modulation of HIV-1 Gag NC/p1 cleavage efficiency affects protease inhibitor resistance and viral replicative capacity.

van Maarseveen NM, Andersson D, Lepšík M, Fun A, Schipper PJ, de Jong D, Boucher CA, Nijhuis M. van Maarseveen NM, et al. Among authors: fun a. Retrovirology. 2012 Apr 1;9:29. doi: 10.1186/1742-4690-9-29. Retrovirology. 2012. PMID: 22462820 Free PMC article.

5

Human Immunodeficiency Virus Gag and protease: partners in resistance.

Fun A, Wensing AM, Verheyen J, Nijhuis M. Fun A, et al. Retrovirology. 2012 Aug 6;9:63. doi: 10.1186/1742-4690-9-63. Retrovirology. 2012. PMID: 22867298 Free PMC article. Review.

6

Impact of the HIV-1 genetic background and HIV-1 population size on the evolution of raltegravir resistance.

Fun A, Leitner T, Vandekerckhove L, Däumer M, Thielen A, Buchholz B, Hoepelman AIM, Gisolf EH, Schipper PJ, Wensing AMJ, Nijhuis M. Fun A, et al. Retrovirology. 2018 Jan 5;15(1):1. doi: 10.1186/s12977-017-0384-z. Retrovirology. 2018. PMID: 29304821 Free PMC article.

7

High prevalence of bevirimat resistance mutations in protease inhibitor-resistant HIV isolates.

Verheyen J, Verhofstede C, Knops E, Vandekerckhove L, Fun A, Brunen D, Dauwe K, Wensing AM, Pfister H, Kaiser R, Nijhuis M. Verheyen J, et al. Among authors: fun a. AIDS. 2010 Mar 13;24(5):669-73. doi: 10.1097/QAD.0b013e32833160fa. AIDS. 2010. PMID: 19926962

8

Clinical use of HIV integrase inhibitors: a systematic review and meta-analysis.

Messiaen P, Wensing AM, Fun A, Nijhuis M, Brusselaers N, Vandekerckhove L. Messiaen P, et al. Among authors: fun a. PLoS One. 2013;8(1):e52562. doi: 10.1371/journal.pone.0052562. Epub 2013 Jan 9. PLoS One. 2013. PMID: 23341902 Free PMC article. Review.

9

Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses.

Hofstra LM, Nijhuis M, Mudrikova T, Fun A, Schipper P, Schneider M, Wensing A. Hofstra LM, et al. Among authors: fun a. J Int AIDS Soc. 2014 Nov 2;17(4 Suppl 3):19755. doi: 10.7448/IAS.17.4.19755. eCollection 2014. J Int AIDS Soc. 2014. PMID: 25397500 Free PMC article.

10

Innovations in the quantitative virus outgrowth assay and its use in clinical trials.

Norton NJ, Fun A, Bandara M, Wills MR, Mok HP, Lever AML. Norton NJ, et al. Among authors: fun a. Retrovirology. 2017 Dec 21;14(1):58. doi: 10.1186/s12977-017-0381-2. Retrovirology. 2017. PMID: 29268753 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

17 results

Search Page

Filters